标题化合物8是由异喹啉酮1(提出的一种改良制剂)合成的,并与D-和L-di-p-甲苯基酒石酸分离成对映体。这些对映体和外消旋体前体已经在两个体内系统中进行了评估(发现具有活性),以证明它们的作用。三种中最有效的(+)-8抑制自发活性的ED50为7.13μmol/ kg,抗伤害感受的ED50为7.45μmol/ kg,而(S)-(分别为4.44和4.81μmol/ kg -)-尼古丁。化合物(-)-8和7的效力约为四分之一。异构体(+)-8具有3aR,9bS构型,后者对应于通过X射线晶体学测定的(S)-(-)-烟碱。但是,(+)-8无法竞争[3H]-烟碱结合,其药理作用并未被美卡明胺阻断。
A New Strategy for Improved Nicotine Vaccines Using Conformationally Constrained Haptens
作者:Michael M. Meijler、Masayuki Matsushita、Laurence J. Altobell、Peter Wirsching、Kim D. Janda
DOI:10.1021/ja034805t
日期:2003.6.1
Constrained nicotine analogues were synthesized and coupled to the carrier protein KLH. The immunogenic effects were compared to those using our previously designed flexible nicotine hapten. Immunization of mice with the constrained hapten conjugates resulted in highly increased antibody titers and affinity for nicotine.
VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION
申请人:Crystal Ronald G.
公开号:US20110086063A1
公开(公告)日:2011-04-14
The invention provides an adenovirus-antigen conjugate comprising an adenovirus with a coat protein and an antigen of an addictive drug conjugated to the coat protein of the adenovirus. The invention also provides an adenoviral vector comprising a nucleic acid sequence which encodes an antibody directed against the addictive drug. The invention further provides a method of inducing an immune response against an addictive drug or reducing the effect of an addictive drug in a human by ad-ministering to the human the aforementioned adenovirus-antigen conjugate or antibody encoding adenoviral vector.
[EN] VACCINES FOR PREVENTION AND TREATMENT OF ADDICTION<br/>[FR] VACCINS POUR LA PRÉVENTION ET LE TRAITEMENT D'UNE DÉPENDANCE
申请人:UNIV CORNELL
公开号:WO2009149252A1
公开(公告)日:2009-12-10
The invention provides an adenovirus-antigen conjugate comprising an adenovirus with a coat protein and an antigen of an addictive drug conjugated to the coat protein of the adenovirus. The invention also provides an adenoviral vector comprising a nucleic acid sequence which encodes an antibody directed against the addictive drug. The invention further provides a method of inducing an immune response against an addictive drug or reducing the effect of an addictive drug in a human by administering to the human the aforementioned adenovirus-antigen conjugate or antibody encoding adenoviral vector.
Synthesis, optical resolution, absolute configuration, and preliminary pharmacology of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo[3,2-h]isoquinoline, a structural analog of nicotine
作者:William Glassco、John Suchocki、Clifford George、Billy R. Martin、Everette L. May
DOI:10.1021/jm00074a019
日期:1993.10
Title compound, 8, has been synthesized from isoquinolinone, 1 (an improved preparation for which is presented) and separated into its antipodes with D- and L-di-p-toluoyltartaric acids. These antipodes and the racemic precursor have been evaluated (and found active) in two in vivo systems for their effects. The most potent of the three, (+)-8, has an ED50 of 7.13 mumol/kg for inhibition of spontaneous
标题化合物8是由异喹啉酮1(提出的一种改良制剂)合成的,并与D-和L-di-p-甲苯基酒石酸分离成对映体。这些对映体和外消旋体前体已经在两个体内系统中进行了评估(发现具有活性),以证明它们的作用。三种中最有效的(+)-8抑制自发活性的ED50为7.13μmol/ kg,抗伤害感受的ED50为7.45μmol/ kg,而(S)-(分别为4.44和4.81μmol/ kg -)-尼古丁。化合物(-)-8和7的效力约为四分之一。异构体(+)-8具有3aR,9bS构型,后者对应于通过X射线晶体学测定的(S)-(-)-烟碱。但是,(+)-8无法竞争[3H]-烟碱结合,其药理作用并未被美卡明胺阻断。
Nornicotine Aqueous Aldol Reactions: Synthetic and Theoretical Investigations into the Origins of Catalysis
作者:Tobin J. Dickerson、Timothy Lovell、Michael M. Meijler、Louis Noodleman、Kim D. Janda
DOI:10.1021/jo048894j
日期:2004.10.1
The recent discovery that nornicotine 1, a minor nicotine metabolite, can catalyze the aldol reaction under physiologically relevant conditions has initiated research efforts into the potential chemical roles of nicotine metabolites. Herein, we disclose studies aimed at determining the origin and thus mechanism of the nornicotine-catalyzed aqueous aldol reaction. Conformationally constrained compounds